|
|
Executive Summary: Anti-Infectives: World Market, 2nd. Ed., Vol. I: AntifungalsPublished by: Kalorama Information Executive Summaries Published: Mar. 1, 2007 - 7 Pages Table of ContentsPlease Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report. AbstractKalorama Information's Executive Summaries provide a comprehensive overview of the contents contained in our full-length market intelligence reports.Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market. The report from which this Executive Summary is compiled is Anti-Infectives, Second Edition, Volume I: Antifungals n, and the full study abstract is as follows: Over one billion people suffer from fungal infections worldwide. Although athlete's foot, dandruff, vaginal yeast infection and fungal nail are the most common, there has been a steady increase in the incidence of more serious infections. This is partially due to the widespread use of antibiotics, which eliminate or decrease fungi-killing bacteria. Another has been the increased number of individuals with reduced immune responses caused by AIDS or the effects of chemotherapy. These are part of the factors that have lead to nearly 6-billion dollar antifungal drug industry.
Anti-Infectives, Second Edition, Volume I: Antifungals is a comprehensive review of the market for anti fungal drugs. This is the first volume of Kalorama Information’s 2nd edition of its popular three-part series on anti-infective markets. The report focuses on two segments of antifungal treatment: systemic and topical. The report covers both currently marketed and late stage development antifungal products in detail. |
|
|||
|
About MarketResearch.com
|
||||